Medigen Biotechnology Corp. (3176)
Market Closed
12 Aug, 05:30
TWSE 
NT$
33. 70
+0.25
+0.7474%
NT$
- Market Cap
- P/E Ratio
- Div Yield
222,274 Volume
- Eps
NT$ 33.45
Previous Close Want to track 3176 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Medigen Biotechnology Corp. (3176) Statistics
Valuation metrics
Market Cap -
Enterprise value 5.37B
Trailing P/E (ttm) -17.74
Forward P/E -
PEG ratio 0.24
Price/Sales (ttm) 3.37
Price/Book (mrq) 3.14
Enterprise Value/Revenue 3.85
Enterprise Value/EBITDA -34.55
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 503.52K
Average volume (90 days) 783.8K
Price summary
52-Week low 28
52-Week high 43.6
Beta -
50-Day moving average 34.04
200-Day moving average 32.81
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1,037:1,000
Last split Date 12 Apr 2012
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -0.19%
Operating margin -0.23%
Operational effectiveness
Return on assets -0.04%
Return on equity -0.17%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 10.01
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.9
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 20.43
Total debt (mrq) -
Total Debt/Equity (mrq) 1.17
Current ratio (mrq) 5.41%
Book value per share (mrq) 33.87
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
